QOL Medical LLC
Vero Beach, FL
- UEI
- M1NNLZQB9HA5
- CAGE
- 3MJX4
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3405 Ocean Dr, Vero Beach, FL 32963, USA
- Website
- qolmed.com
- Founded
- 2003
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $109,153 |
| FY2025 | $48,876 |
| FY2024 | $81,433 |
| FY2023 | $463,574 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of Veterans Affairs | $109,153 |
Contract vehicles
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Travere Therapeutics, Inc. | San Diego, CA | 325412 Pharmaceutical Preparation Manufacturing |
| Recordati Rare Diseases Inc. | Bridgewater, NJ | 325411 Medicinal and Botanical Manufacturing |
| United Therapeutics Corp | Silver Spring, MD | 325412 Pharmaceutical Preparation Manufacturing |
| Vifor (International) AG | St. Gallen, SG | 325412 Pharmaceutical Preparation Manufacturing |
| Amneal Pharmaceuticals Of New York, LLC | Medford, NY | 325412 Pharmaceutical Preparation Manufacturing |
About the company
QOL Medical LLC, a specialty biopharmaceutical manufacturer based in Vero Beach, Florida, supplies SUCRAID (sacrosidase) oral solution, an enzyme replacement therapy for congenital sucrase-isomaltase deficiency, to the Veterans Health Administration as a prime contractor exclusively through the GSA Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB), with no subcontractor involvement and no set-aside designations across its federal footprint.
QOL Medical holds an established GSA Schedule master contract with a ceiling of approximately $4.5 million and operates as a specialty pharmaceutical vendor focused on orphan and rare-disease treatments. The company competes full-and-open and has not pursued SBA set-asides. Recent representative delivery orders include a $33,890.20 firm fixed price order from Veterans Integrated Service Network 5 issued April 2, 2026, a $32,425.76 order from VISN 9 in October 2024, and a $128,033.84 order from VISN 6 in October 2022, all for SUCRAID oral solution under the Pharmaceuticals and Drugs Schedule. A significant volume of orders span VISN 8 and VISN 9 emergency pharmacy requests, typically valued between $11,600 and $37,200 and completed within days to weeks of award to address urgent VA healthcare supply needs.
Customer concentration is exclusively within the Department of Veterans Affairs. The top five VISN customers by award count account for 83 percent of awards, led by VISN 9 (21 awards, $393 thousand combined potential value) and VISN 8 (6 awards, $221 thousand). However, by potential value dollars, VISN 12 dominates with 3 awards worth $6.9 million combined, followed by the VA National Acquisition Center with a single $442 thousand award. This divergence reflects occasional larger institutional procurements against VISN 12, while VISN 9 and VISN 8 drive order frequency through routine and emergency pharmacy replenishment. All 46 prime awards in the recent portfolio sit on the Pharmaceuticals and Drugs GSA Schedule (37 task orders, $1.3 million combined potential value).
Activity declined from 11 awards in 2022 to 3 in 2026 year-to-date, reflecting the intermittent, demand-driven nature of emergency pharmaceutical procurement. The source data spans from 2004 to August 2026, with most awards clustered between 2021 and 2024. Combined potential value across all 46 awards totals $8.5 million, though only $985 thousand has been obligated to date (12 percent of combined potential), consistent with the firm fixed price, short-duration delivery-order structure typical of GSA Schedule pharmaceutical replenishment. Place of performance is Vero Beach, Florida for all awards, where QOL Medical maintains manufacturing and distribution operations serving the VA's nationwide integrated service networks.
Quick answers
Is QOL Medical LLC registered in SAM.gov?
Yes. QOL Medical LLC's SAM.gov registration is active through July 14, 2027.
Which contract vehicles does QOL Medical LLC hold?
QOL Medical LLC holds a place on 1 federal contract vehicle: FSS-61-IB.
How much has QOL Medical LLC received in federal contracts?
Federal contracts obligated $48,876 to QOL Medical LLC in fiscal year 2025 and $703,036 in fiscal years 2023 through 2027.
What is QOL Medical LLC's most recent federal award?
QOL Medical LLC's most recent federal contract award is Sucraid 8500 UNT/ML soln (36C24526N0837), from Veterans Integrated Service Network 5 (VHA), on August 27, 2026.
On GovTribe
See QOL Medical LLC's full federal record
- Federal contract awards
- IDV awards
- Contract vehicles
- Funding analysis by agency, NAICS and set-aside
- Similar vendors